Images

Filter by

Comparison of Efficacy Outcomes Between Dual Antithrombotic Therapy with Dabigatran and Triple Antithrombotic Therapy with Vitamin K Antagonist Stratified by the Presence of Clinical and/or Procedural Complexity Factors in the REDUAL PCI Trial Population
Comparison of Efficacy Outcomes Between Dual Antithrombotic Therapy with Dabigatran and Triple Antithrombotic Therapy with Vitamin K Antagonist Stratified by the Presence of Clinical and/or Procedural Complexity Factors in the REDUAL PCI Trial Population
Comparison of Safety Outcomes Between Dual Antithrombotic Therapy with Dabigatran and Triple Antithrombotic Therapy with Vitamin K Antagonist Stratified by the Presence of Clinical and/or Procedural Complexity Factors in the REDUAL PCI Trial Population
Comparison of Safety Outcomes Between Dual Antithrombotic Therapy with Dabigatran and Triple Antithrombotic Therapy with Vitamin K Antagonist Stratified by the Presence of Clinical and/or Procedural Complexity Factors in the REDUAL PCI Trial Population
Comparison of Safety Outcomes Between Dual Antithrombotic Therapy with Rivaroxaban and Triple Antithrombotic Therapy with Vitamin K Antagonist Stratified by Procedure and Lesion Characteristics in the PIONEER AF-PCI Trial Population
Comparison of Safety Outcomes Between Dual Antithrombotic Therapy with Rivaroxaban and Triple Antithrombotic Therapy with Vitamin K Antagonist Stratified by Procedure and Lesion Characteristics in the PIONEER AF-PCI Trial Population
Comparison of Efficacy Outcomes Between Dual Antithrombotic Therapy with Rivaroxaban and Triple Antithrombotic Therapy with Vitamin K Antagonist Stratified by Procedure and Lesion Characteristics in the PIONEER AF-PCI Trial Population
Comparison of Efficacy Outcomes Between Dual Antithrombotic Therapy with Rivaroxaban and Triple Antithrombotic Therapy with Vitamin K Antagonist Stratified by Procedure and Lesion Characteristics in the PIONEER AF-PCI Trial Population
Major Randomized Controlled Trial Subgroup Analyses in Patients with AF Undergoing Complex Percutaneous Coronary Intervention
Major Randomized Controlled Trial Subgroup Analyses in Patients with AF Undergoing Complex Percutaneous Coronary Intervention
Other Basket Electrogram-based Mapping Systems in Patients With AF
Other Basket Electrogram-based Mapping Systems in Patients With AF
Schematics of Basket and Sequential Electrogram-based Mapping Approaches in Patients With AF
Schematics of Basket and Sequential Electrogram-based Mapping Approaches in Patients With AF
Technical Considerations of Selected Studies Using Novel Mapping Systems in Patients With Persistent AF*
Technical Considerations of Selected Studies Using Novel Mapping Systems in Patients With Persistent AF*
Technical Considerations of Selected Studies Using Novel Mapping Systems in Patients With Persistent AF*
Technical Considerations of Selected Studies Using Novel Mapping Systems in Patients With Persistent AF*
Panoramic and Sequential Phase-mapping Approaches in Experimental Settings and in Patients With AF
Panoramic and Sequential Phase-mapping Approaches in Experimental Settings and in Patients With AF
Clinical Data of Selected Studies Using Novel Mapping Systems in Patients with Persistent AF*
Clinical Data of Selected Studies Using Novel Mapping Systems in Patients with Persistent AF*
Relative Survival Rates of Patients Receiving Subcutaneous Treprostinil
Relative Survival Rates of Patients Receiving Subcutaneous Treprostinil